{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:50:18Z","timestamp":1740138618241,"version":"3.37.3"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T00:00:00Z","timestamp":1538179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The European & Developing Countries Clinical Trials Partnership"},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South African National Research Foundation"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ijid.2018.09.024","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T12:54:48Z","timestamp":1538657688000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-1585","authenticated-orcid":false,"given":"Poobalan","family":"Naidoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliasgar","family":"Esmail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Davids","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-5341","authenticated-orcid":false,"given":"Keertan","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"November (6)","key":"10.1016\/j.ijid.2018.09.024_bib0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tube.2011.05.007","article-title":"Clinical symptoms and microbiological outcomes in tuberculosis treatment trials","volume":"91","author":"Bark","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"issue":"June (6)","key":"10.1016\/j.ijid.2018.09.024_bib0010","article-title":"The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study","volume":"7","author":"Cohen","year":"2010","journal-title":"PLoS Med"},{"issue":"March (10024)","key":"10.1016\/j.ijid.2018.09.024_bib0015","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet"},{"issue":"March (3)","key":"10.1016\/j.ijid.2018.09.024_bib0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(13)70250-0","article-title":"Diagnostic point-of-care tests in resource-limited settings","volume":"14","author":"Drain","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.ijid.2018.09.024_bib0025","article-title":"Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study","volume":"5","author":"Drain","year":"2015","journal-title":"BMJ Open"},{"issue":"March (1)","key":"10.1016\/j.ijid.2018.09.024_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12916-016-0603-9","article-title":"Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Gupta-Wright","year":"2016","journal-title":"BMC Med"},{"issue":"September (6)","key":"10.1016\/j.ijid.2018.09.024_bib0035","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.ijid.2009.11.030","article-title":"Abdominal tuberculosis: sonographic diagnosis and treatment response in HIV-positive adults in rural South Africa","volume":"14","author":"Heller","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"September (6)","key":"10.1016\/j.ijid.2018.09.024_bib0040","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","article-title":"Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion","volume":"180","author":"Johnson","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"July (7)","key":"10.1016\/j.ijid.2018.09.024_bib0045","article-title":"Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis","volume":"9","author":"Kerkhoff","year":"2014","journal-title":"PLoS One"},{"issue":"December","key":"10.1016\/j.ijid.2018.09.024_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1741-7015-11-253","article-title":"Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review","volume":"11","author":"Lawn","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2018.09.024_bib0055","first-page":"798764","article-title":"Tuberculous meningitis: diagnosis and treatment overview","volume":"2011","author":"Marx","year":"2011","journal-title":"Tuberc Res Treat"},{"issue":"March (10024)","key":"10.1016\/j.ijid.2018.09.024_bib0060","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial","volume":"387","author":"Peter","year":"2016","journal-title":"Lancet"},{"issue":"September (3)","key":"10.1016\/j.ijid.2018.09.024_bib0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jinf.2009.06.011","article-title":"British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children","volume":"59","author":"Thwaites","year":"2009","journal-title":"J Infect"},{"year":"2015","series-title":"The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Policy guidance. WHO\/HTM\/TB\/2015.25","author":"World Health Organization","key":"10.1016\/j.ijid.2018.09.024_bib0070"},{"issue":"December (12)","key":"10.1016\/j.ijid.2018.09.024_bib0075","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7196\/SAMJ.9090","article-title":"The diagnosis, management and prevention of HIV-associated tuberculosis","volume":"104","author":"Wasserman","year":"2014","journal-title":"S Afr Med J"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T13:45:10Z","timestamp":1565271910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971218345430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":15,"alternative-id":["S1201971218345430"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.09.024","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the use of adjunct urine lipopolysaccharide lipoarabinomannan in HIV-infected hospitalized patients reduce the utilization of healthcare resources? A post hoc analysis of the LAM multi-country randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}